Arijana Mestrovic

Dr. Arijana Mestrovic

Doc dr sc Arijana Mestrovic, MPharm, FFIP
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in American Journal of Pharmaceutical Education
Verified
Journal Article
Closed access
Arijana MestrovicArijana Mestrovic
Arijana Mestrovic
MRMichael J. Rouse
Michael J. Rouse

10 September 2016 in Pharmacy
Verified
Journal Article
Open access
PDF file
Ieva StupansIeva Stupans
Ieva Stupans
JAJeffrey Atkinson
Jeffrey Atkinson
Arijana MestrovicArijana Mestrovic
Arijana Mestrovic
RNRose Nash
Rose Nash
MRMichael J Rouse
Michael J Rouse
This paper presents an analysis of the end of degree expectations, expressed as learning outcomes, for pharmacy graduates from Australia, Canada, United Kingdom and United States. The authors compare the end of degree expectations, through mapping these requirements to the International Pharmaceutical Federation (FIP) Global Competency Framework (GbCF). The anticipated end of degree expectations are similar but also reveal some individual characteristics. Irrespective of degree title, achievement of learning outcomes specified in any one of the four jurisdictions should enable students to become pharmacists who are patient-orientated medicines experts. The mapping provides impetus for cross-border institutional networking to generate a dependable set of assessment tools across national borders developing a common metric for outcome assessment irrespective of different program delivery.

6 August 2020 in Pharmacy
Verified
Journal Article
Open access
PDF file
MRMichael J Rouse
Michael J Rouse
Arijana MestrovicArijana Mestrovic
Arijana Mestrovic
The SMART Pharmacist Program was initiated by the Accreditation Council for Pharmacy Education (ACPE) and Pharma Expert in 2014. It was designed to introduce a new continuing education model for pharmacists for the Turkish Pharmacists’ Association, and to support development of competencies for future practice. After successful implementation in Turkey, the Program spread to 16 additional countries. To assure quality, globally adopted and validated tools and best practices were used, respecting the national context. National competency frameworks and quality indicators for pharmaceutical care delivery were developed. Pharmacists’ learning portfolios were introduced and patient care modules created. Under the sub-title “Learn Today—Apply Tomorrow,” the changes in practice were introduced under the leadership of national host organizations. The Program showed an impact on the patient level in several countries, especially in areas of patient care in Asthma and Chronic Obstructive Pulmonary Disease (COPD), Hypertension and Dyslipidemia, Diabetes, and the patient care process in general (e.g., identifying drug-related problems, improving patient safety, collaborating with medical doctors). Changes are visible at the individual (pharmacists) and organizational levels. Barriers and facilitators to the change-management process during Program implementation are identified. In some countries, the Program is recognized as one of the most important initiatives in pharmacy education and practice, with visible support of national medicines agencies, academia, government, and WHO regional offices.

18 September 2022 in Pharmacy Education
Verified
Journal Article
Closed access
PDF file
Arijana MestrovicArijana Mestrovic
Arijana Mestrovic
AAAsmaa Al-Haqan
Asmaa Al-Haqan
MEMarwan El-Akel
Marwan El-Akel
NANaoko Arakawa
Naoko Arakawa
BMBanan Abdulrzaq S. Mukhalati
Banan Abdulrzaq S. Mukhalati
CDCatherine Duggan
Catherine Duggan
The FIP (International Pharmaceutical Federation) Global Competency Framework for Educators and Trainers in Pharmacy (FIP-GCFE) is an ongoing project of the Academic Pharmacy Section of FIP in cooperation and collaboration with Sections, Special Interest Groups and Working Groups across the Federation. It was developed by a group of experts in pharmaceutical education to enable and promote the continuing professional development of pharmacists and pharmaceutical scientists who plan to advance their competence as educators and trainers in pharmacy and the pharmaceutical sciences, whether in a formal or informal context, and at all levels of education and professional development. The FIP-GCFE will be an essential resource for multiple stakeholders including individual educators, faculties of pharmacy, and accreditation agencies. This article presents the introductory text of the GCFE first version, connecting previously launched concepts and tools and explaining the integration with all other FIP workforce support frameworks, to provide a holistic approach to global workforce development.

14 September 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
ATAnita Tuula
Anita Tuula
Daisy VolmerDaisy Volmer
Daisy Volmer
LJLiisa Jõhvik
Liisa Jõhvik
IRIeva Rutkovska
Ieva Rutkovska
ITIndrė Trečiokienė
Indrė Trečiokienė
Michael ScottMichael Scott
Michael Scott
Polypharmacy is a common issue in patients with chronic diseases. Eastern-European countries and Iran are exploring possibilities for implementing the Medication Use Review (MUR) as a measure for optimizing medication use and ensuring medication safety in polypharmacy patients. The aim of this study was to gain insights into the development of the community pharmacy sector and map facilitators and barriers of MUR in Eastern Europe and Iran. The representatives of the framework countries received a questionnaire on community pharmacy sector indicators, current and future developments of pharmacies, and factors encouraging and hindering MUR. To answer the questionnaire, all representatives performed document analysis, literature review, and qualitative interviews with key stakeholders. The socio-ecological model was used for inductive thematic analysis of the identified factors. Current community pharmacist competencies in framework countries were more related to traditional pharmacy services. Main facilitators of MUR were increase in polypharmacy and pharmaceutical waste, and access to patients’ electronic list of medications by pharmacists. Main barriers included the service being unfamiliar, lack of funding and private consultation areas. Pharmacists in the framework countries are well-placed to provide MUR, however, the service needs more introduction and barriers mostly on organizational and public policy levels must be addressed.

22 March 2023 in Pharmacy
Verified
Journal Article
Open access
PDF file
TŠTatjana Šipetić
Tatjana Šipetić
DRDragana Rajković
Dragana Rajković
NSNataša Bogavac Stanojević
Nataša Bogavac Stanojević
VMValentina Marinković
Valentina Marinković
Arijana MestrovicArijana Mestrovic
Arijana Mestrovic
MRMichael J Rouse
Michael J Rouse
This study aims to demonstrate the improvements in clinical symptoms in patients with post-COVID syndrome after a community pharmacy-based intervention in Serbia. The Pharmaceutical Chamber of Serbia (“Chamber”) invited pharmacists to deliver post-COVID patient care counselling, supported by the SMART Pharmacist Program, offering education and guidance. Present symptoms, duration and patient self-reported severity of symptoms on a scale of 1–5 on the first visit were recorded. After the counselling and proposed self-medication treatment, the time of the follow-up visit and the severity of the recorded symptoms were also recorded. The prospective data collection lasted from December 2021 to September 2022. In total, 871 patients with post-COVID symptoms were included in the study, served by 53 pharmacists. The most frequently reported post-COVID symptoms coincided with the literature, mostly related to the respiratory system (51.2%), immunity status (32.2%), fatigue and exhaustion (30.7%), skin, hair and nails (27.4%) and cognitive functions (27.9%). A total of 26.5% of patients were referred to their family physician (general practitioner), and 69.5% returned to the pharmacist for a follow-up visit. On the first visit, the median severity of patients’ symptoms was three, while on the second visit it dropped to one. The pharmacists’ intervention led to a significant improvement in the post-COVID patients’ condition.